ADM Biopolis|Bifidobacterium longum CECT7347

ADM Biopolis Bifidobacterium longum CECT7347 | Clinically Supported Probiotic

Product Features

【Clinically Supported・Published in International Journals】
Efficacy studies have been published in leading international journals, including British Journal of Nutrition and Minerva Gastroenterologica, providing strong clinical validation.

 

【Infant-Origin Strain・Postbiotic Functionality】
Derived from infant gut microbiota, this strain functions as a postbiotic after metabolism, supporting digestive health and nutrient balance.

 

【International Recognition・Award-Winning Innovation】
Recipient of multiple international innovation awards, including:
・2023 Fi Europe – Health Innovation Award
・2024 Fi Europe – Innovation Award
・2023 “Top 100 Food Industry Innovation” Award

Certifications

  • Animal studies conducted・In vitro studies conducted・Human clinical studies conducted
  • QPS・GRAS

Product Information

Brand ADM
Origin Spain
Specifications 1,000 billion CFU per gram
Patent No HALAL Yes
Applications Supports digestion and nutrient absorption・Supports digestive tract function・Helps maintain microbial balance・Comprehensive nutritional supplementation・Gut health support
Manufacturer Research Available Vegetarian Type Vegan

Formula & Ingredient Recommendations

Fiberest® resistant dextrin
Digezyme® Multi-digestive enzyme
Galactooligosaccharide